| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537072 | Vaccine | 2017 | 8 Pages |
Abstract
Funding: Seqirus Pty Ltd; Clinicaltrials.gov identifier: NCT02545543.
Keywords
TDOCIIV3TaurodeoxycholateFASGMTGMFISAEstandard deviationUnited StatesSafetyImmunogenicityfull analysis setSPRadverse eventSerious adverse eventinactivatedconfidence intervalhemagglutination inhibitionGeometric mean titerSeroconversion rateSeroprotection rateinfluenza vaccineTrivalent inactivated influenza vaccineQuadrivalentChildrenSCR
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jolanta Airey, Frank R. Albano, Daphne C. Sawlwin, Alison Graves Jones, Neil Formica, Vince Matassa, Jane Leong,